TrialJournal of radiation research2023

A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal (the JROSG 10-2 trial).

Keiko Nemoto Murofushi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.